Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...

Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data

Strong Buy on WVE-N531 and WVE-006 catalysts, Phase data, and cash runway into 2028. Click for this WVE stock update.

重磅！2026年5月ESI高被引论文阈值发布

5月14日，科睿唯安（Clarivate Analytics）公布了2026年5月的ESI最新数据。 注：ESI的正常更新时间为每奇数月的第二个星期四。 Essential Science Indicators (ESI) 是一种分析工具，可帮助识别 ...
China.org.cn

Xi urges faster building of Chinese intellectual system in philosophy, social sciences

Chinese President Xi Jinping has stressed accelerating the building of a Chinese intellectual system in philosophy and social ...

美股异动 | Conexeu Sciences(CNXU.US)登陆美股市场 开盘跌超3.6%

立足香港，放眼世界。新浪财经全球资本峰会金曜奖投票启动！挖掘最具价值的资本力量，你的一票，至关重要 点击投票 周四，Conexeu Sciences(CNXU.US)登陆美股市场，开盘股价跌超3.6%，报13.01美元。IPO价格为13.5美元。Conexeu Sciences是一家美国早期医疗科技公司，专注于开发基于胶原蛋白的再生医学材料，主要用于伤口修复、牙科软组织修复以及医美领域。公司总部位 ...
Nature

Hallucinated citations highest in social sciences preprints site

More than 140,000 fake citations across four research repositories were identified in papers and preprints published in 2025 ...

Anavex Life Sciences Corp.的资讯和分析评论

Anavex Life Sciences公布了2026年第一季度每股亏损（EPS）为-0.06美元，超过了此前预测的-0.12美元。公司拥有1.317亿美元的强劲现金储备，并且没有债务。 研发（R&D）支出从1040万美元大幅降至470万美元，表明随着公司推进其产品线，运营效率得到了提高。 尽管盈利表现积极，Anavex的股票在盘前交易中略微下跌了0.24%，交易价格为4.09美元，其52周波动范 ...
National Academies of Sciences%2c Engineering%2c and Medicine

New Voices Program for Emerging STEM Leaders Announces 2026 Cohort

WASHINGTON — The National Academies of Sciences, Engineering, and Medicine’s New Voices in Sciences, Engineering, and Medicine program has announced its 2026-2028 cohort of members, a group of 20 ...